Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER_GOV × Esophageal Neoplasms × Clear all

Phase

Phase 2 12 Phase NA 8 Phase 3 7 Phase 1 4 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

OTHER 13 UNKNOWN 2 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4 Neoplasms 3 Rectal Neoplasms 2 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Leukemia, Myeloid, Acute 2 Carcinoma, Hepatocellular 2 Warts 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oesophagogastric Cancer 1 Neoplasm Metastasis 1 Leukopenia 1 Leukemia, Biphenotypic, Acute 1 Insulin Resistance 1 Infertility 1 Hydatidiform Mole 1 Glioma 1 Gestational Trophoblastic Disease 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Disease 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Advanced Solid Tumor 1

Interventions

Radiotherapy 1 Paclitaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02741856 2018-10-25

SCOPE2

Velindre NHS Trust

Phase 2/3 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡